Clinical trial
Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care…
NCT00315237 · Pierre Fabre Medicament, Industry · Completed
Key facts
| NCT number | NCT00315237 |
|---|---|
| Title | Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract |
| Official title | Prospective, Randomized Phase III Trial of I.V. Vinflunine Plus Best Supportive Care as Second Line Therapy Versus Best Supportive Care After a Platinum-containing Regimen, in Patients With Advanced Transitional Cell Carcinoma of Urothelial Tract |
| Lead sponsor | Pierre Fabre Medicament, Industry |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Transitional Cell Carcinoma of the Urothelial Tract, Bladder Cancer, Bladder Neoplasms |
| Intervention type | Drug |
| Interventions | vinflunine and best supportive care |
| Enrollment | 364 |
| Start date | Jul 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Apr 18, 2006 |
| Last update posted | Jan 7, 2010 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: